The cost-effectiveness of a bimekizumab versus IL-17A inhibitors treatment-pathway in patients with active axial spondyloarthritis in Scotland.
Article in Journal of Medical Economics (April 2024)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Article in Journal of Medical Economics (April 2024)
Article in Family medicine European practices (February 2024)
Article in Rheumatology (February 2024)